New York Hospitals Conducting COVID-19 Drug Trial Using Common Heartburn Medicine
- 4 years ago
Researchers are looking into whether high doses of famotidine could be used to treat COVID-19 patients.
Business Insider reports that Famotidine is the active ingredient in the heartburn medication Pepcid.
A clinical trial is currently underway, with researchers aiming to recruit 1,200 patients.
The trial is investigating if high doses of famotidine help critically ill coronavirus patients survive.
Researchers are using a dose that's nine times the amount of famotidine typically used to treat heartburn.
Researchers note that there's no evidence yet from the trial that suggests famotidine is helping.
Business Insider reports that Famotidine is the active ingredient in the heartburn medication Pepcid.
A clinical trial is currently underway, with researchers aiming to recruit 1,200 patients.
The trial is investigating if high doses of famotidine help critically ill coronavirus patients survive.
Researchers are using a dose that's nine times the amount of famotidine typically used to treat heartburn.
Researchers note that there's no evidence yet from the trial that suggests famotidine is helping.